「ag」の検索結果
48件：26～30件目を表示
-
发表论文 | 研究与开发 | 千寿制药株式会社
83:163-175. VIEW PUBLICATION Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Perspectives in Japa...
http://www.senju.co.jp/chinese/rd/thesis/ -
学会发表 | 研究与开发 | 千寿制药株式会社
株式会社 See more 海外 AAO 2025 開催日：2025年10月17日～2025年10月20日 開催地：Orlando, FL, USA Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Piv...
http://www.senju.co.jp/chinese/rd/society/ -
Quality Policies | About Senju | SENJU Pharmaceutical
t the following "Quality Policies" and continue to be a "Good Company" by encouraging cooperation among all employees and providing high-quality products for "realization of p...
http://www.senju.co.jp/english/about/quality.html -
千寿製薬株式会社
BAC-free formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with Brill International（PDF） February 20, 2025 Launch and Distribution of “MIEr for Beeli...
http://www.senju.co.jp/english/ -
お知らせ | 千寿製薬株式会社
BAC-free formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with Brill International（PDF） February 20, 2025 Launch and Distribution of “MIEr for Beeli...
http://www.senju.co.jp/english/news/